Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText.
Kick-your-searchterm to multiple Engines kick-your-query now !>
A dictionary by aggregated review articles of nephrology, medicine and the life sciences
Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

suck abstract from ncbi


10.13345/j.cjb.200049

http://scihub22266oqcxt.onion/10.13345/j.cjb.200049
suck pdf from google scholar
32347055!ä!32347055

suck abstract from ncbi


Warning: Undefined variable $yww in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 538

Warning: Undefined variable $yww in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 538
pmid32347055      Sheng+Wu+Gong+Cheng+Xue+Bao 2020 ; 36 (4): 605-611
Nephropedia Template TP

gab.com Text

Twit Text FOAVip

Twit Text #

English Wikipedia


  • Role of cyclophilin A during coronavirus replication and the antiviral activities of its inhibitors #MMPMID32347055
  • Tian L; Liu W; Sun L
  • Sheng Wu Gong Cheng Xue Bao 2020[Apr]; 36 (4): 605-611 PMID32347055show ga
  • Cyclophilin A (CypA) is a widely distributed and highly conserved protein in organisms. It has peptidyl-prolyl cis/trans isomerase activity and is a receptor for cyclosporin A (CsA). Coronaviruses are enveloped, single-stranded, positive-sense RNA viruses. Seven types of coronaviruses are currently known to infect humans, among which SARS-CoV, MERS-CoV, and SARS-CoV-2 are fatal for humans. It is well established that CypA is essential for the replication of various coronaviruses such as SARS-CoV, CoV-229E, CoV-NL63, and FCoV. Additionally, CsA and its derivatives (ALV, NIM811, etc.) have obvious inhibitory effects on a variety of coronaviruses. These results suggest that CypA is a potential antiviral target and the existing drug CsA might be used as an anti-coronavirus drug. At the end of 2019, SARS-CoV-2 raged in China, which seriously theatern human health and causes huge economic lases. In view of this, we describe the effects of CypA on the replication of coronaviruses and the antiviral activities of its inhibitors, which will provide the scientific basis and ideas for the development of antiviral drugs for SARS-CoV-2.
  • |*Coronavirus Infections/drug therapy/epidemiology/virology[MESH]
  • |*Pandemics[MESH]
  • |*Pneumonia, Viral/drug therapy/epidemiology/virology[MESH]
  • |Antiviral Agents/*pharmacology/therapeutic use[MESH]
  • |Betacoronavirus/drug effects/growth & development[MESH]
  • |COVID-19[MESH]
  • |Coronavirus/*drug effects/*growth & development[MESH]
  • |Cyclophilin A/*antagonists & inhibitors[MESH]
  • |Cyclosporine/chemistry/*pharmacology/*therapeutic use[MESH]
  • |Humans[MESH]
  • |SARS-CoV-2[MESH]
  • |Severe acute respiratory syndrome-related coronavirus/drug effects/growth & development[MESH]


  • DeepDyve
  • Pubget Overpricing
  • suck abstract from ncbi

    Linkout box